Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Discusses Autonomous Robotics Platform and ExynAI Engine for Navigation and Mapping in GPS-Denied Environments June 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results